{"id":"W2062369750","doi":"10.1111/j.1477-2574.2012.00441.x","title":"Meta-analysis of Phase III randomized trials of molecular targeted therapies for advanced pancreatic cancer","year":2012,"lang":"en","type":"review","venue":"HPB","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Gemcitabine; Medicine; Internal medicine; Hazard ratio; Meta-analysis; Confidence interval; Odds ratio; Pancreatic cancer; Placebo; Oncology; Randomized controlled trial; Cancer; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.008441024,0.0004543071,0.04086737,0.0007779381,0.00003285801,0.000004264131,0.0002061413,0.0003549148,0.004401782],"category_scores_gemma":[0.002878468,0.0002448461,0.0127723,0.000830632,0.0003118286,0.00003348021,0.00003338676,0.0002056473,0.000003166817],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000744675,"about_ca_system_score_gemma":0.0007702187,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001546136,"about_ca_topic_score_gemma":0.000007596474,"domain_scores_codex":[0.9931639,0.002440089,0.003166391,0.0003548587,0.0004923212,0.0003824777],"domain_scores_gemma":[0.9870785,0.008923599,0.002653183,0.0007085066,0.0004753323,0.0001608918],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01915155,0.0003722956,0.000003162106,0.0120284,0.7277055,0.000003625217,0.0001795266,0.000001078523,0.0001769084,0.00009419807,0.00006001929,0.2402238],"study_design_scores_gemma":[0.08774588,0.0001810674,4.79841e-7,0.0005735839,0.8366019,0.000001740975,0.00002215021,0.0001535892,0.00006808315,0.00002253827,0.07447696,0.0001520451],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002648191,0.9836135,0.007392691,0.00003325123,0.00006288583,0.007645778,0.0008096131,0.00001392935,0.0001635146],"genre_scores_gemma":[0.000163322,0.9827839,0.008891453,0.00003940511,0.00007074566,0.005790002,0.0005964415,0.00005078049,0.001613967],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2400717,"threshold_uncertainty_score":0.9984533,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.323072457906405,"score_gpt":0.5175700520400595,"score_spread":0.1944975941336545,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}